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The IPC-81 cell line is derived from the transplantable BNML model of acute myelogenic leukemia (AML), known to be a reliable
predictoroftheclinicalefﬁciencyofantileukemicagents,liketheﬁrst-lineAMLanthracyclinedrugdaunorubicin(DNR).Weshow
here that cAMP acted synergistically with DNR to induce IPC cell death. The DNR-induced death differed from that induced by
cAMP by (1) not involving Bim induction, (2) being abrogated by GSK3b inhibitors, (3) by being promoted by the HSP90/p23
antagonist geldanamycin and truncated p23 and (4) by being insensitive to the CRE binding protein (CREB) antagonist ICER and
to cyclin-dependent protein kinase (CDK) inhibitors. In contrast, the apoptosis induced by cAMP correlated tightly with Bim
proteinexpression.ItwasabrogatedbyBim(BCL2L11)downregulation,whetherachievedbytheCREBantagonistICER,byCDK
inhibitors, by Bim-directed RNAi, or by protein synthesis inhibitor. The forced expression of BimL killed IPC-81WT cells rapidly,
Bcl2-overexpressing cells being partially resistant. The pivotal role of CREB and CDK activity for Bim transcription is
unprecedented.It isalsonoteworthy that newly developedcAMP analogsspeciﬁcally activatingPKA isozymeI(PKA-I) wereable
to induce IPC cell apoptosis. Our ﬁndings support the notion that AML cells may possess targetable death pathways not
exploited by common anti-cancer agents.
Cell Death and Disease (2011) 2, e237; doi:10.1038/cddis.2011.124; published online 8 December 2011
Subject Category: Cancer
The second messenger cAMP regulates fundamental cell
processes, including cell survival, differentiation and proli-
feration, mainly by activating cAMP-dependent protein kinase
I,II (PKA-I, PKA-II) or cAMP-stimulated exchange factors
Epac1,2 (see
1 and references therein). The IPC-81 acute
myelogenic leukemia (AML) cells
2 undergo apoptosis within
4–6h after cAMP stimulation.
3 The cells are also sensitive
to ﬁrst-line anti-leukemic drugs like daunorubicin (DNR) both
in vitro and in vivo.
4 This may reﬂect their origin from the
BNML model of leukemia, considered reliable to judge the
clinical efﬁcacy of anti-leukemic drugs.
5 The IPC cell provides
therefore a unique opportunity to compare the cell death
induced by a physiologically relevant endogenous second
messenger and a chemotherapeutically relevant agent.
Intriguingly, the cAMP-induced IPC cell death is blocked by
the cyclin-dependent protein kinase (CDK) inhibitor roscov-
itine (RCV),
6 which (under trade name Seliciclib) is used
against cancer.
7,8 Equally intriguing, the cAMP-induced death
is blocked by overexpression of ICER,
9 which competitively
inhibits the access of the cAMP-responsive gene promoter
elements binding protein (CREB) transcription factor family
members to CRE.
10 ICER is considered an AML tumor
suppressor and CREB an AML oncogene.
11–13
The present study was undertaken to know how the
normally proapoptotic RCV and ICER could block the
cAMP-induced IPC cell death. We wanted also to know
the relative roles of PKA-I, PKA-II and Epac in the death
induction. For this purpose, new PKA-I selective cAMP
analogs were developed and used, together with previously
developed analogs discriminating between PKA and
Epac.
14,15 Finally, we wanted to know the relation, if any,
between cAMP- and anthracycline-induced IPC cell death.
We found that activation of PKA-I was necessary and
sufﬁcient for cAMP-induced IPC cell death. The death
was dependent on Bim induction, whose transcription was
dependent both on CREB and RCV-inhibited CDK activity.
In contrast, neither Bim induction, CREB activity or RCV-
inhibitable CDK activity affected anthracycline-induced IPC
cell death, which depended on glycogen synthase kinase
3b (GSK3b) activity and was promoted by disruption of the
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ilar apoptosis induction mechanism, cAMP synergized
strongly with anthracycline to induce IPC cell death. We
conclude that IPC cells have a potent cAMP-induced cell
death pathway unexploited by ﬁrst-line chemotherapeutics.
Results
Strong PKA-I activation induces IPC cell apoptosis,
whereas the basal PKA activity is necessary to maintain
growth and survival. The apoptosis induced (Figure 1a) by
cAMP stimulation of IPCWT allow the probing of both cAMP
signaling and apoptosis pathways. We studied ﬁrst whether
the cAMP receptor Epac could be co-responsible with PKA
for the death induction. The Epac-speciﬁc activator 8-CPT-
20-O-Me-cAMP failed, however, to induce any apoptosis
alone (Figure 1a) or to enhance the apoptosis induced by the
PKA-speciﬁc activator N
6-MB-cAMP (not shown; see also
Supplementary Section IV). To probe the role of PKA more
directly, the cells were stably transduced with short hairpin-
based RNAi directed against the catalytic Ca subunit of
PKA, and selected for survival after 48h exposure to an
apoptogenic concentration of cAMP analog. The surviving
clones expressed from 25–60% of the normal amount of
catalytic kinase activity (Figure 1b). This suggests that at
Figure 1 Activation of PKA-I, but not Epac or PKA-II, induces CRE-dependent IPC cell apoptosis counteracted by Bcl2. (a) The upper row show that IPCWT AML cells
underwent apoptosiswith cell fragmentationand chromatin condensation after 5h incubationwith either 200mM of thecAMP analog 8-CPT-cAMP,which activates both PKA
and Epac or 700mM of the PKA-speciﬁc analog N
6-MB-cAMP.The speciﬁcEpac activator 8-CPT-20-O-Me-cAMP (700mM) did not induce any apoptosis. Rows 2,3 showthat
the Bcl2 overexpressing IPC cells (IPCBCL2) or IPC cells with enforced expression of the CREB antagonist ICER (IPCICER) were protected against apoptosis by the same
cAMP analogs. (b) The PKA activity was determined (at saturating cAMP concentration) in extracts of IPCWT and four cAMP-resistant IPC clones stably transduced with
shRNAi against thecatalytic (Ca) subunit of PKA. (c) Thepanel shows the newcAMP analog 2-Cl-8-AHA-cAMP,highly selectivefor site BI of PKA isozyme I (Supplementary
Table S2), to be an inefﬁcient inducer of IPCWT apoptosis alone (J). When combined with the new site AI-speciﬁc analog N
6-Bnz-8-Pip-cAMP (300mM), its efﬁciency
was enhanced 420-fold (K). This analog pair is expected to synergize strongly for PKA-I activation (inset), but not for PKA-II (Supplementary Table S3). (d and e) The
analogs Sp-5,6-DCl-cBIMPS and N
6-MB-cAMP (J) were, respectively, moderately (d) and only marginally (e) more efﬁcient when combined with N
6-Bnz-8-Pip-cAMP (K).
TheinsetsshowtheirexpectedPKA-Isynergy(fromSupplementaryTableS3).NotethatN
6-Bnz-8-Pip-cAMP(300mM)hadonlylittleeffect(5%increaseoftheIPCcelldeath)
when present alone (c–e). Error bars indicate S.E.M., n¼3–8
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Cell Death and Diseaseleast 60% of the normal PKA content is required for cAMP-
induced apoptosis to occur. The RI subunit of PKA-I
comprises about 75% of the total R subunit expressed in
IPCWT cells, the remaining 25% being RII associated with
PKA-II.
16 An isolated activation of PKA-I might therefore be
sufﬁcient to induce apoptosis.
To enable speciﬁc activation of PKA-I, cAMP analog
combinations with improved isozyme selectivity were synthe-
sized. The new PKA-I selective analogs N
6-Bnz-8-Pip-cAMP
and 2-Cl-8-AHA-cAMP discriminate better than any previous
cAMPanalogsbetweenthecAMPbindingsites(A,B)ofPKA-I
and PKA-II (Supplementary Tables S1–S3). They acted in
strong synergy to induce cAMP-dependent apoptosis
(Figure 1c). When N
6-Bnz-8-Pip-cAMP was combined with
other cAMP analogs, a moderate (Figure 1d) or barely any
(Figure 1e) synergy was achieved. The observed synergies
are in accordance with predictions based on the analog cAMP
binding site preferences (Supplementary Table S3), and
therefore unlikely to be due to nonspeciﬁc side effects. Note
also that the concentration of paired analogs yielding
synergistic death induction was far lower than that required
for each analog alone (Figure 1). We conclude that IPC cell
apoptosis can be induced by the isolated activation of PKA-I.
Although a strong activation of PKA leads to IPC cell death,
the basal activity seemed necessary for growth. In fact, some
of the surviving shRNAi-transfected clones showed slow
growth, sometimes associated with mitotic arrest. That the
slow growth was due to low PKA activity was supported by
the demonstration of improved growth of clone Lo45-II in the
presence of a low concentration (20mM) of cAMP analog
(8-CPT-cAMP). This clone had about 25% of the normal PKA
content, against about 40–60% for three surviving clones that
didnotdependonaddedcAMPforoptimalgrowth(Figure1b).
In conclusion, PKA appears to have a dual role. It induces
death when strongly activated, but its basal activity is
necessary to avoid growth arrest.
Cyclic AMP operates mainly through CRE-dependent
factors to regulate the IPC cell transcriptome.
The cAMP-induced death is prevented in IPC cells
overexpressing the truncated cAMP responsive element
modulator (CREM) variant ICER
9 (Figure 1a). ICER blocks
the access to the cAMP-responsive elements (CRE) of gene
promoters.
10 A functional CRE is required for the action of
the CREB, CREM, ATF-1 family of transcription factors.
17,18
The IPCICER cells might be protected because ICER alters
the basal gene expression or because it prevents the acute
regulation by cAMP of one or more genes required for
apoptosis to occur. The basic transcriptome was very similar
in IPCWT and IPCICER cells (not shown). This suggested that
few CRE-dependent gene regulation events took place at
basal cAMP concentration in the cells, and that ICER acted
to modulate the acute effect of cAMP on gene transcription.
We found nearly 40 named genes to be 42-fold upregu-
lated and 15 to be 42-fold downregulated after incubation for
2h with an apoptogenic concentration of the PKA-directed
cAMP analog N
6-MB-cAMP (Figures 2a–d). As cAMP can
affect mRNA expression via other transcription factors than
CREB/CREM
19 and affect mRNA stability independently
of transcription,
20 we expected ICER to block only a subset
of the cAMP-induced effects on mRNA expression. This
subset would be particularly relevant to search for candidate
genes to mediate the cAMP-induced death as IPCICER
cells are quite insensitive to cAMP-induced death (see
9 and
Figure 1a). ICER overexpression blunted most of the effects
of cAMP on the IPC cell transcriptome, including the
upregulation of Bim (BCL2L11) mRNA (Figure 2a). We
conclude that most cAMP-induced regulations of IPC cell
gene mRNA expression are mediated via the CRE/CREB
system.
That Bim is regulated by cAMP via the CRE/CREB system
was unexpected. The rat Bim promoter contains CRE-sites
able to recruit CREB,
21 but as they are TATA-less,
22 the
bound CREB is not supposed to recruit the cofactors
necessary for cAMP/CREB-induced transcription
17 (see also
Supplementary Section V). In general, the IPC cells obey the
rule that a TATA-box is required in the proximity of a CRE
element to allow CREB-dependent regulation via cAMP.
Thus, the TATA-less DNA-damage inducible transcript 4
(Ddit4) was induced equally by cAMP in wild-type and ICER-
overexpressing cells (Figure 2a; Supplementary Table S4).
In IPCBCL2 cells, cAMP induces maturation/differentiation
rather than death (see
23 and Figure 1a). We used them
therefore to exclude that any of the cAMP-induced effects on
transcript expression in IPCWT cellswere secondaryto events
linked to the apoptotic process. We found similar cAMP
regulation of the transcriptome of IPCWT and of IPCBCL2 cells,
also for genes considered to be potentially pro-apoptotic
or involved in development and cell differentiation
(Figures 2a–d). In conclusion, cAMP regulates IPC cell gene
expression mainly through CRE-dependent transcription,
unaffected by Bcl2 overexpression.
Five genes (JAK2, CEBPB, MADD, cMyc, Bim/BCL2L11)
with cAMP-upregulated transcripts were classiﬁed (Figure 2e)
as potential apoptosis inducers (Supplementary Table S5;
panther database). Of these, Bim showed the strongest
upregulation. Closer study revealed seven Bim transcript
variants in the cAMP-stimulated IPC cells (Figure 3).
In addition to the previously described isoforms BimEL, BimL
and BimS and Bimb4,
24 we identiﬁed novel (Z) variants of
BimEL, BimL, and BimS, characterized by an extra exon
(Figure 3b). The novel transcript variants were expressed at
0.1–10% the level of their previously described counterparts.
The induction by cAMP based on qRT-PCR was robust
(about 30-fold) and similar for both the novel and known Bim
transcripts (Figure 3d). That cAMP induced all gene variants
suggested that cAMP had little effect on the Bim splicing
pattern.
The endogenous Bim expression is tightly coupled to
death in cAMP-stimulated IPC cells. The CDK inhibitor
RCV nearly abolished the induction of Bim mRNA, indi-
cating that Bim mRNA transcription involves a CDK-
dependent step. The Bim mRNA expression appeared to
be independent of new protein synthesis as it was unaffected
by cycloheximide (CHX) (Figure 4a).
As the cAMP-induced IPC cell death is blocked by both
CHX and RCV,
3,6 these ﬁndings suggested that Bim induction
might be important for the death. If so, a correlation should
exist between cell death and Bim protein expression, whether
cAMP , Bim and AML cell death
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Cell Death and Diseasemanipulated by interference with Bim-mRNA synthesis (RCV)
or Bim-mRNA translation (CHX). We achieved a graded
expression of Bim protein (see insets and right hand axes of
Figures 4b and c) by adding RCV (Figure 4b) or CHX
(Figure 4c) at successive time points after the addition of
cAMP. In either case, Bim protein expression correlated
tightly with apoptosis, as determined 6h after the onset of
cAMP stimulation.
cAMP , Bim and AML cell death
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Cell Death and DiseaseTo provide a more direct link between cAMP-induced
apoptosis and Bim transcript induction, we knocked down the
Bim transcript. The restriction enzyme-based method used to
achieve IPC cells with knocked-down Ca (Figure 1b) was not
feasible owing to lack of suitable restriction enzyme sites in
the Bim-cDNA. We therefore designed synthetic RNAi
hairpins to target the part of the Bim transcript coding for the
common N-terminal part of all the detected Bim isoforms. The
hairpin DNA was inserted into vectors to produce retrovirus
and stably transduce IPCWT cells. Two of the selected clones
were compared with a clone expressing non-target (lucifer-
ase) hairpin RNAi for apoptosis induction after incubation with
Figure 2 Gene expression analysis of IPC cells exposed to the PKA-activating cAMP analog N
6-MB-cAMP. IPCWT or IPC cells stably over-expressing ICER (IPCICER)o r
Bcl2 (IPCBCL2), were exposed for 2h to the PKA activator N
6-MB-cAMP (700mM). The transcriptome was analyzed by Affymetrix gene array (U230A, 15866 probe sets).
(a) The 82 transcripts increased(red) or decreased (blue) 42-fold in either IPCWT or IPCICER or IPCBCL2 are shown in a hierarchical clusteringdiagram. Genes in green have
known cAMP responsive elements (CRE) in the promoter region from  3000 to þ300 bases from the transcriptional start site. (b and c) The Venn diagram circles show the
number and overlap of transcripts upregulated (b) or downregulated (c) 42 fold by N
6-MB-cAMP in IPCWT (grey), IPCICER (cyan), and IPCBCL2 (pink) cells. (d) The panel
showsthatthefoldregulationbyN
6-MB-cAMPinIPCWTcellscorrelateswell(r
2¼0.866)withthatinIPCBCL2cells(D),butpoorly(r
2¼0.287)withthatintheIPCICERcells(O).
Thedottedlinerepresentsperfectcorrelation.Notethatonlytranscriptsregulatedmorethan2-foldareincluded.(e)Biologicalprocessesover-representedamongtheN
6-MB-
cAMP regulated genes according to the http://www.pantherdb.org tool are shown. Two processes had signiﬁcantly fewer and seven had more regulated genes than the
average. The P-values ranged from 0.003* (intracellular protein transport) to 0.047 (protein metabolic process). The number of regulated genes for each process is shown
above each bar (see Supplementary Table S5 for details)
Figure 3 Several Bim isoforms are expressed in cAMP-stimulated IPC cells. (a) Overview of the Bim gene exons (size in base pairs) with localization of the BH3-domain,
startandstoptranslationalcodons,sites targetedbytheAffymetrixprobesets,andtheepitopeoftheanti-Bimantibodyused.(b) SchemeoftheBimmRNAformsdetectedin
IPCcellsexposedto 8-CPT-cAMP(100mM)for2h.Theknownmajorisoforms(BimEL/L/S), Bimb4,thenovelvariantZ-BimLwithan additionalexondownstream oftheBH3
encoding exon, were sequenced from ampliﬁed cDNA. Two additional variants (Z-BimEL and Z-BimS) were detected by RT-PCR (see Supplementary Table S7a and
MaterialsandMethodsfordetails).ThepredictedMW(rightcolumn)isshownforeachvariant.(c)ThelevelofthesixBH3-containingBimtranscriptvariantswasestimatedby
qRT-PCR,usingspeciﬁcprimerpairs.Thefoldinductionisshownafter3hincubationwith8-CPT-cAMP(200mM),whentheexpressionrelativetotheBimLtranscriptreached
65% for BimEL and for BimS, and 5, 11, and 0.1% for the novel variants Z-BimEL, Z-BimL, and Z-BimS, respectively. The results are the mean of three independent
experiments±S.E.M. (d) The fold change in Bim-transcript after 2h incubation with N
6-MB-cAMP, based on hybridization to the three microarray probe sets (color code as in
panel a). Note the blunted response to N
6-MB-cAMP in the IPCICER, but not the IPCBCL2 cells
cAMP , Bim and AML cell death
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Cell Death and Disease8-CPT-cAMP. The hairpin-transduced cells were compared
with non-target RNAi-transduced cells for ability to develop
apoptosis in response to the cAMP analog 8-CPT-cAMP. The
hairpin1 transduced cells showed very little apoptosis
(Figures 5a and c) and low expression of Bim (Figure 5c,
inset). Hairpin 2 gave less-efﬁcient knockdown of Bim
(Figure 5d) and protection against apoptosis (Figures 5a
and d), but still provided signiﬁcant protection as compared
with the vector control (Figure 5b).
In conclusion, an excellent correlation is observed between
Bim expression and apoptosis in cAMP-stimulated IPC cells,
whether the Bim expression is manipulated by RCV, CHX or
various Bim-directed shRNAi hairpins.
Enforced BimL expression induces IPC apoptosis
independently of cAMP and more strongly in IPCWT
than IPCBCL2 cells. In order to test whether Bim expression
alone is sufﬁcient to induce apoptosis in the IPCWT cells, they
were transfected retrovirally with a bicistronic vector for BimL
and GFP (BimL). Cells transfected with vector coding only for
GFP served as control (pMIG). GFP-positive IPCWT and
IPCBCL2 cells were observed 18h after virus transduction
with control vector. About 50% of the cells were detectably
green 36h after the transfection (not shown). No GFP
positive cells were apparent after transduction with vector for
with BimLþGFP. Nevertheless, a high proportion of the cells
were apoptotic (Figure 5e). A likely explanation is that the
retroviral-driven BimL expression induces apoptosis too
rapidly for the cells to synthesize detectable GFP before
undergoing death. The death morphology was classically
apoptotic (Figure 5e, left inset), and strikingly similar to that
induced by cAMP (Figure 1a).
The IPCBCL2 cells subjected to BimLþGFP transduction
showed much less overall apoptosis than the similarly
transduced IPCWT cells (Figure 5f). Some of the apoptotic
cells were GFP positive (Figure 5f, left inset). This suggests
that some of the BimL-transfected IPCBCL2 cells underwent
apoptosisslowlyenoughtosynthesizeadetectableamountof
GFP before dying. We conclude that ectopically expressed
BimL is a highly efﬁcient inducer of IPC cell apoptosis, whose
effect is counteracted, but not completely abolished, by Bcl2
overexpression.
Cyclic AMP and DNR induce IPC cell death
synergistically via distinct mechanisms. Cyclic AMP
induces early mitochondrial damage in IPC cells.
25 It
resembles in this respect the intrinsic death induced by
common chemotherapeutic drugs like DNR.
26 In spite of this
similarity DNR does not affect Bim protein expression
(Figure 6a). This may explain why DNR-induced death is
independent on CDK activity (Supplementary Figure S1d)
and insensitive to ICER overexpression (Supplementary
Figure S3). Another distinction was that the effect of DNR,
but not cAMP, was abrogated by inhibitors of the generally
pro-apoptotic GSK3b protein kinase (Supplementary Figures
S1b and c).
The ansamycin antibiotic geldanamycin (GA) antagonizes
HSP90 by disrupting its association with p23.
27 The p23
function is also compromised by caspase-mediated p23
truncation.
28 We show that DNR and cAMP-stimulation both
Figure 4 The cAMP-induced apoptosis correlates closely with Bim protein
expression.(a)TheBim-mRNAexpressioninIPCWTcellsexposedfor0,0.5,1,2,or
5h to 200mM 8-CPT-cAMP was determined by qRT-PCR, using primers covering
all detected isoforms (see Figure 3b and Supplementary Table S7a). Co-incubation
with the protein synthesis inhibitor CHX (36mM) had only marginal effect on the
transcript expression, whereas the CDK inhibitor RCV (15mM) prevented the
induction of Bim-mRNA. (b) The inset shows an immune-blot probed with anti-pan-
Bim antibody of extracts from IPC cells treated for 4h with 8-CPT-cAMP (200mM)
withnoaddedRCV( )or15mMRCVaddedsimultaneouslywithcAMPanalog(0),
or 1,2 or 3h thereafter. The numbers on the left correspond to MW of standard
proteins. Actin was used as loading control. The main part of the panel shows the
relativeexpressionof BimELafter 4h incubationwith 8-CPT-cAMP, as a functionof
time after RCV addition (D), and its correlation with the % apoptotic cells, as
determined in parallel experiments where the incubations were continued until 6h
after 8-CPT-cAMP was added (K). (c) Panel c is similar to panel b except that
CHX (36mM) rather than RCV was added. The data for all panels show average
values±S.E.M. from 3–7 independent experiments. A close correlation is
noted between apoptosis and BimEL expression (r
2¼0.95 for panel b and 0.97
for panel c)
cAMP , Bim and AML cell death
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Cell Death and Diseaselead to p23 truncation (Figure 6a). On the other hand, GA only
enhancestheDNR-inducedIPC celldeath(Figures 6band e).
This questioned the importance of the observed p23 cleavage
for cAMP-induced death. To probe its importance, we
prepared retroviral stable expression vectors for truncated
p23 (Dp23), mimicking the endogenously formed p23 clea-
vage product, as well as a caspase cleavage-resistant
(p23D142/145A) p23 (Figure 6d). We found no signiﬁcant
difference in cAMP-sensitivity between mock-transfected
cells and cells expressing caspase-resistant p23 or Dp23
(Figure 6c). In contrast, the DNR-induced apoptosis was
signiﬁcantly higher in the Dp23-transduced cells than in the
p23D142/145A-transduced cells (Figure 6f). That p23 clea-
vage can sensitize cells to DNR was supported further by
experiments on HEK293T cells (Supplementary Figure S2).
We conclude that the cAMP- and DNR-induced cell death
differs fundamentally regarding both Bim induction and
effect of inhibition of CDK, GSK3 and HSP90/p23 activity.
This suggests that DNR-resistant AML cells may have
alternative death pathways that can be exploited therapeuti-
cally. In fact, cAMP and DNR synergized for IPC cell death
induction (Figure 7). A considerable decrease of the cAMP
analog dose required to induce apoptosis was achieved by
using PKA-I synergistic cAMP analog pairs instead of single
analogs (Figure 1). The use of analog pairs should therefore
allow lessening of the cAMP analog load for potential clinical
use. A further decrease should be achieved by acetoxy-
methyl-ester prodrugs of the analogs, which have improved
cell permeability.
29
Discussion
Cyclic AMP signaling has versatile roles in hematopoiesis.
They range from stimulation of proliferation to maturation and
cell death.
30,31 The presently studied IPC cell line reﬂects this
versatility and places PKA as the pivotal cAMP mediator.
PKA appears to have a delicate role in balancing the IPC cell
proliferation. Cells expressing o40% of the C subunit of PKA
Figure5 Bim-shRNAiprotectsagainstcAMP-inducedapoptosis,whereasectopicBimLexpressioninducesapoptosis.(a)IPCcellswereretrovirallytransfectedforstable
expressionusingtwodifferentconstructsagainstBim(Bim-shRNA1orBim-shRNA2).Thenon-targetcontrolwasshRNAiagainstluciferase(LUC-shRNA).Afterselection,the
cellswereexposedtovariousconcentrationsof8-CPT-cAMP(6h)and%apoptoticcellsdetermined.(b)IPCLUC shRNAcellsweretreatedwith80mM8-CPT-cAMPforvarious
periods of time and % apoptotic cells determined. The inset shows an immune-blot as for Figures 4b and c. The position of BimEL and BimL is indicated. (c and d)
IPCBim shRNA1 (c) or IPCBim shRNA2 (d) cells were treated and analyzed for apoptosis as for panel (b). In addition, the level of Bim was assayed by immunoblots (insets) of
extracts from cells exposed to 8-CPT-cAMP for 1, 1.5 or 2h. (e) IPCWT cells were infected with retrovirus for bicistronic expression of BimL and GFP or for expression of GFP
alone (pMIG). Only the BimL-transduced cells showed apoptosis 18h after infection. (f) IPCBCL2 cells similarly infected and scored for apoptosis showed less, but signiﬁcant
apoptosis. The dying IPCBCL2 cells infected with vector for bicistronic expression of BimL and GFP showed GFP expression (left inset)
cAMP , Bim and AML cell death
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Cell Death and Diseaseor being treated with PKA inhibitor (Rp-8-Br-cAMPS) are
growth arrested. The high basal (resting state) cAMP level in
IPC cells
32 may therefore be an adaption required to activate
the PKA enough to sustain proliferation. On the other hand,
strong PKA activators arrest the cells at the G1/S restriction
point.
3
Although the basal cAMP level is sufﬁcient to sustain
proliferation, it appears not to induce net CRE-dependent IPC
cell transcription. Thus, the basal state IPC transcriptome is
similar in wild-type cells and cells overexpressing the CRE-
blocking ICER protein (not shown). In contrast, the gene
expression is profoundly altered in ICER-transfected HL-60
cells.
11 It is also puzzling in view of the notion of CREB as an
AML oncogene and marker for therapy resistance and ICER
as a tumor suppressor.
11,13 The lack of CRE-dependent
transcription in the basal state is not due to deﬁcient CREB
response. A number of transcripts are induced in an ICER-
inhibitable manner in cells incubated with a PKA-directed
cAMP analog. It may rather be related to the nature of
the induced transcripts. They code for proteins involved in
apoptosis or differentiation/development (Figure 1e), rather
than growth and survival.
Anearcompleteneutrophilicmaturationcanbeachievedby
cAMP stimulation of IPC cells stably overexpressing Bcl2.
23
Bcl2 can enhance maturation by directly affecting gene
expression, as shown for the hematopoietic differentiation of
murineembryonicstemcells.
33WeﬁndsimilarcAMP-induced
transcriptomes of IPCWT and IPCBCL2 cells. Bcl2 may
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Figure 6 ThecAMP-inducedIPC cell apoptosisdiffers from DNR-induced apoptosiswith respect to Bimexpressionand role of HSP 90 modulators. (a) Extracts fromIPC
cells treated with vehicle for 2h (left Ctr) or 6h (right hand Ctr), with 8-CPT-cAMP (200mM) for 2h, 4h, or 6h, or with 0.4mM DNR for 6h were probed for Bim, HSP90
cochaperone p23 and actin by immunoblotting. Note that p23 cleavage is unaccompanied by Bim induction of the DNR-exposed cells. (b) Apoptosis was scored for IPC cells
exposed to 0.5mM GA alone or together with 8-CPT-cAMP (200mM). (c) IPC cells retrovirally transfected with CRU5-IRES-GFP (empty vector), CRU5-IRES-GFP-p23
D142/145A (p23 D142/145A) or CRU5-IRES-GFP-p23 1–142 aa (Dp23) were treated with 8-CPT-cAMP (200mM; 6h) and scored for apoptosis. The 3–5% apoptosis in
vehicle-treatedcellsissubtracted.(d)Celllysatesfromcellstransfectedasforpanelcweretreatedwithvehicle(Ctrl)orDNR(0.4mM;6h),andanalyzedforp23,HSP90,and
actin expression by immunoblotting. Note that cells transduced with Dp231–142 expressed Dp23 also before challenge with DNR. (e) IPC cells were treated with DNR
(0.4mM)inthepresenceorabsenceof GA(500mM)andapoptosisscored.(f)Theclonesdescribedin(c)weretreatedwith DNR(0.4mM;6h)andscoredfor apoptosis.Bars
represent mean±S.E.M., n¼3–8, and P-values are estimated using student t-test
Figure 7 Synergism between death induced by anthracycline and cAMP.
IPCWT cells were preincubated for 2h in the absence or presence of N
6-MB-cAMP
at a sub-apoptogenic concentration (175mM) (Figure 1e). Thereafter the cells
were added vehicle (0) or DNR to 0.1, 0.2, 0.3 or 0.4mM concentrations. 3.5h
thereafter, the cells were ﬁxed and assessed for apoptosis. Note the strikingly
enhanced effect of DNR for cells pre/co-incubated with the cAMP analog. Data
represent mean±S.E.M. (n¼4)
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Cell Death and Diseasetherefore promote differentiation indirectly, by simply allowing
the cAMP-induced maturation program to progress without
being overwhelmed by apoptosis, as in the IPCWT cells.
The most striking effect of IPCWT cell PKA activation is
apoptosis induction, which occurs much more rapidly than
in the S49 thymocyte cell line, which also depends on
Bim-induction.
34 We found that Bim protein expression
correlates closely with apoptosis. This is true whether Bim
expression is manipulated by the CDK inhibitor (RCV), Bim-
directed shRNAi, or by protein synthesis inhibitor (CHX). Bim
is a plausible death inducer. It elicits intrinsic cell death by
neutralizing the anti-apoptotic effects of Bcl2, Bcl-XL and
Mcl-1, as well as through more direct pathways
35,36 (see also
Figure 8). In fact, the forced expression of BimL led to rapid
death of IPCWT cells and more attenuated death of IPCBCL2
cells (Figure 5). A high proportion of the cAMP-induced
Bim protein was of the BimEL variant, which is a substrate for
PKA.
37 It is therefore possible that cAMP may contribute
to IPC cell death also by activating phosphorylation
37 of the
already induced BimEL protein. The role of Bim may reﬂect
that the IPC cells have retained death pathway components
operating in normal myeloid-derived cells. Bim is a negative
regulator of normal hematopoesis
35 and accelerates the
demise of mature neutrophilic granulocytes.
38 It appears
thereforethattheIPCcellshaveretainednormalbonemarrow
properties like pleiotropic response to cAMP and Bim-
dependent death induction.
The induction of Bim by cAMP has some unusual features.
It occursvery rapidly, is mediated via CRE/CREB, and depends
completely on CDK activity (Figures 2–4). The mediation by
CRE/CREB is puzzling as the conserved CRE’s of the
Bim promoter are TATA-less and therefore not expected to be
regulated by CREB.
17 Antagonists of CDK7,9, like RCV, target
the elongation of a subset of gene transcripts.
39 The impact of
CDK activity on Bim-expression appears not to have been
explicitly studied, but is probably not universal. Thus,
RCV causes depletion of anti-apoptotic proteins like Mcl-1 in
neutrophilic granulocytes, but spares Bim,
40 nevertheless
our ﬁndings suggest some caution in using RCV in tumors
depending on Bim expression for eradication.
Figure 8 Overview of the pathway(s) incriminated in cAMP-induced IPC cell apoptosis. (1) The binding of cAMP to both sites on the regulatory subunits of the PKA
holoenzyme leads to release of free, active catalytic subunits. (2) Catalytic PKA subunit translocated to the nucleus can phosphorylate the transcription regulatory proteins of
theCREBfamily(CREB,CREM,ATFs),whichbindtoavailableCREsinthepromoterregionofCREB-regulatedgenes.TheBim-promotercontainsfourhalfCREsites,twoof
whichisconservedandseparatedbyonly13bpabout500bpupstreamfromthetranscriptionstartsite.TheCREMisoformICERblocksCREsitesandtherebytheactionofall
CRE-binding transcription factors. Phosphorylated CREB recruits the basal transcriptional machinery via CREB-binding protein (CBP/P300) and other co-factors and
adaptors. (3) Transcript elongation is stimulated by phosphorylations of the C-terminal domain of RNA polymerase II by members of the CDK family, especially CDK7 and 9,
whicharesensitivetoinhibitionbyRCV.
39(4)ThetranslationofBim-mRNAisinhibitedbyCHX.(5and6)TheBimproteincancomplexBcl2andtherebyblockBcl2prosurvival
functions. Bim may (dotted line) also induce apoptosis by stimulating BAX/BAK directly. The dotted arrows from PKA to (5 and 6) is based on the observation that cAMP can
synergize with DNR to induce apoptosisin IPCICER cells (Supplementary Figure S3), which do not die in response to cAMP alone (Figure 1a). The dottedarrows from RCV to
(5 and 6) are based on the moderate inhibition of cAMP-induced IPC cell death by dominant negative CDK5,
6 which might be through inhibition of death processes
downstream of Bim mRNA transcription
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Cell Death and DiseaseThe strong IPC cell response to anthracyclines is unsur-
prising in view of their origin from the transplantable BNML
model of AML, considered a reliable predictor of the clinical
efﬁcacy of antileukemic drugs.
5 The IPCBCL2 cells are
protected both against cAMP and the ﬁrst-line anti-leukemic
drug DNR. Furthermore, both death inducers promote the
cleavageoftheHSP90cochaperonep23(Figure6).Inspiteof
these similarities, the cAMP and DNR-induced death did not
proceed by a basically common pathway. Firstly, the p23
cleavage has consequence in DNR-induced death only
(Figures 6b and e). Although the enforced expression of
cleavage-resistantp23protectedandtruncatedp23promoted
DNR-induced death, they failed to affect cAMP-induced death
(Figures 6c and f; Supplementary Figure S2). Similarly, the
HSP90/p23-targeting drug GA only promoted the DNR-
induced death (Figures 6b and e). Secondly, Bim is induced
uniquely in cAMP-induced death (Figure 6a). Thirdly, CDK
antagonism inhibits only the cAMP-induced death, whereas
GSK3b antagonism only inhibits the DNR-induced death
(Supplementary Figure S1).
Inconclusion,theIPCcellsdemonstratetheco-existenceof
an extremely efﬁcient PKA-CRE-CDK- and Bim-dependent
pathway in addition to a p23- and GSK3b enhanced
anthracycline-induced death pathway. Studies aimed at
exploring the therapeutic usefulness of the components of
the PKA-CRE-CDK-Bim-dependent pathway may be war-
ranted. It is of interest that PKA-I selective cAMP analogs can
induce IPC AML cell death and that Bim transcription can
be mediated through CRE sites. The IPC cell sensitivity to
inhibitors of CDK’s and GSK3b (Supplementary Figure S1)
may be exploited to test the in vivo efﬁcacy of CDK and
GSK3b activity modulators. Finally, the new observations
regarding the control by cAMP of initiation and elongation of
Bim transcript may spur new studies on the expression of this
important gene.
Materials and Methods
Reagents and constructs. The cAMP analogs were from BioLog (Bremen,
Germany). The new A and B-site-speciﬁc cAMP analogs and the paullone analogs
for CDK5 and GSK3b inhibition are described in Supplementary Section IV. RCV,
GA and DNR were obtained from Sigma (St. Louis, MO, USA). The pMIG-Bim
(Addgene plasmid 8786, Cambridge, MA, USA) was kindly made available for the
scientiﬁc community by Dr. SJ Korsmeyer. The vectors for Ca knockdown are
described in Supplementary Section IV. To create expression vectors for shRNAi
against Bim, HPLC-puriﬁed synthetic oligo DNA (see Supplementary Table S7b for
sequences) were annealed and ligated into the Aar1 site of the retroviral shRNAi
vector L087 (GenBank Acc: EU424173). Mutated and truncated versions of p23
28
were subcloned into vectors for transient transfection of HEK293T cells and stable
retroviral transfection of IPC cells (see Supplementary Section IV for details).
Cell culture and retroviral transfection. Wild-type (IPCWT), ICER- and
Bcl2-overexpressing (IPCICER, IPCBCL2) clonesof the IPC-81leukemiacell line
2,9,23
were obtained from Dr. M Lanotte, Hop St. Louis, Paris. They were grown in DMEM
(Sigma) supplemented with 10% heat-inactivated horse serum (EuroClone, Milan,
Italy), and kept in logarithmic growth phase. Before experiments, the cells were
resuspended in fresh growth medium. The Phoenix retroviral producer cell line was
a kind gift from Dr. J. Lorens. They were grown in DMEM with 10% fetal bovine
serum (EuroClone) and pen/strep as described above. By splitting every 2nd or 3rd
day,conﬂuentcellswereavoided.Thedaybeforetransfection,cellswereplatedata
density of 150000cells/cm
2. Transfection of phoenix cells was carried out by the
calcium phosphate method. For a 10cm
2 well, 2mg VSV-G plasmid together with
5mgplasmidofinterestwasused.Viruseswereharvestedafter24(Bimexpression)
or 48h (p23 and shRNAi expression), and up-concentrated by centrifugation at
50000 g for 3h, and resuspended in phosphate-buffered saline over night.
IPC cells were infected in growth medium with protamine sulfate (5mg/ml, Sigma)
under centrifugation (1500 g 90min). For stable expression of Bim shRNAi,
puromycin (Sigma) selection was started at 0.1mg/ml 48h after infection and
gradually increased up to 1mg/ml within 2 weeks.
Determination of apoptotic morphology and kinase activity. IPC
cell apoptosis was assessed in formaldehyde-ﬁxed (2% ﬁnal concentration) cells.
Apoptosis was assessed by phase contrast microscopy of the surface morphology,
and ﬂuorescence microscopy of the nuclear morphology after staining of DNA with
bisbenzimide, Hoechst 33342 (Sigma). To determine cAMP-dependent protein
kinase activity in IPC cells lysate, radioactive phosphate incorporation to kemptide
was performed as previously described.
32
Microarray analysis. IPC cell RNA was isolated with a combination of TRI
reagent (Sigma) and GenElute columns (Sigma). The manufacturer’s protocol for
TRI reagent was followed but instead of precipitation of the RNA, the aqueous
solution was mixed with ethanol (ﬁnal 35%) and applied to GenElute silica columns
andwashedandelutedaccordingtotheGenEluteprotocol.Themicroarrayanalysis
on U230A rat transcriptome chip from Affymetrix (Santa Clara, CA, USA) was
according to standard procedures at the Norwegian Microarray consortium Oslo.
Theprocessingoftheexpressiondata,annotationsandcAMPresponsiveelements
in the promoter region is described in the Supplementary Section IV.
Cloning of Bim transcript variants. RNA from 8-CPT-cAMP-stimulated
IPC cells was reverse transcribed and ampliﬁed by PCR with primers given in
Supplementary Table S7a. The PCR product was ligated into the pcDNA5/FRT/V5-
His TOPO vector (Invitrogen, Carlsbad, CA, USA), and cloned to E.coli DH5a.
Plasmid from ampicillin-resistant clones were isolated and sequenced. The
sequences were aligned to known Bim transcripts and the genomic Bim sequence.
Quantitative RT-PCR and western blot. For quantitative RT-PCR, RNA
was isolated with TRI reagent (Sigma) according to the protocol from the
manufacturer. 1mg of RNA was reverse transcribed with revert-aid Mu-MLV
transcriptase (Fermentas GmbH, St. Leon-Rot, Germany)and oligo-dT primers and
a speciﬁc reverse primer for 18S ribosomal RNA (18S). qPCR were run with a
Lightcycler 480 II (Roche, Basel, Switzerland) using iQ SYBR green supermix
(BioRad, Richmond, CA, USA). cDNA corresponding to 25ng RNA were used in
each PCR reaction. Primer sequences are given in Supplementary Table S7a. Bim
expression was quantiﬁed relative to untreated control and the expression was
normalized to the average of succinate dehydrogenase complex subunit alpha and
18S ribosomal RNA.
SDS gel electrophoresis and western blots were done and band intensity
evaluated essentially as described previously.
28 The membrane were probed with
either: rabbit polyclonal anti-Bim (Cat No 202000, EMD Biosciences, San Diego,
CA, USA), mouse monoclonal anti-ﬂag (M2, Sigma), anti-Hsp90 (SPA-830,
Stressgen, Victoria, Canada), mouse monoclonal anti-actin (ab6276 Abcam,
Cambridge, UK) or mouse monoclonal anti-p23 (JJ3, generously supplied by Dr.
David O Toft, Mayo Clinic, Rochester, MN, USA). Bands representing the proteins
of interest were detected using alkaline-phosphatase-conjugated secondary
antibodies (a-3687 and a-3562 Sigma) and CDP-Star substrate (Tropix, Bedford,
MA, USA) and detected in a Fuji LAS3000.
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